Literature DB >> 195004

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

D A Thorley-Lawson, L Chess, J L Strominger.   

Abstract

Studies have been performed on in vitro infection by Epstein-Barr virus (EBV) of subpopulations of human lymphocytes. B cells of adult peripheral or fetal cord blood transform with equal efficiency, whether assayed by DNA synthesis induction or by outgrowth of transformed lymphocytes. In contrast, unfractionated adult lymphocytes transform much less efficiently than those from fetal cord. Reconstitution experiments of different cell preparations indicated that this difference was due to a suppression of B-cell proliferation by adult Ig-negative lymphocytes which fetal Ig-negative lymphocytes were unable to perform. Separation of Ig-negative lymphocytes into various subpopulations revealed that the suppression was performed by T cells. Macrophages and null cells play little or no role in suppression. The relevance of this phenomenon to infection and recovery from EBV infection during and after infectious mononucleosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195004      PMCID: PMC2180764          DOI: 10.1084/jem.146.2.495

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Different Ly antigen phenotypes of in vitro induced helper and suppressor cells.

Authors:  M Feldmann; P C Beverley; M Dunkley; S Kontiainen
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

2.  Comparison between two antibody populations in the EBV system: anti-MA versus neutralizing antibody activity.

Authors:  A de Schryver; A Rosén; P Gunvén; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

3.  Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.

Authors:  M F Greaves; G Brown
Journal:  Clin Immunol Immunopathol       Date:  1975-03

4.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

5.  Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.

Authors:  J Robinson
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

6.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

7.  Independent movement of IgD and IgM molecules on the surface of individual lymphocytes.

Authors:  W Knapp; R L Bolhuis; J Rádl; W Hijmans
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

8.  Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone.

Authors:  P M Sondel; L Chess; R P MacDermott; S F Schlossman
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

9.  Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.

Authors:  R Kiessling; G Petranyi; K Kärre; M Jondal; D Tracey; H Wigzell
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

10.  Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization.

Authors:  T Takemori; T Tada
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  59 in total

1.  Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis.

Authors:  M McDermott; M Molloy; J Buckley; J Greally
Journal:  Ir J Med Sci       Date:  1989-08       Impact factor: 1.568

2.  Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.

Authors:  Nancy H Gudgeon; Graham S Taylor; Heather M Long; Tracey A Haigh; Alan B Rickinson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 3.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

Review 4.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

6.  Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein.

Authors:  D A Thorley-Lawson; E S Israelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.

Authors:  T Häupl; G R Burmester; G Hahn; U Feige; C Rordorf-Adam; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

Authors:  K P Mann; D Staunton; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Impaired T lymphocyte colony formation in infectious mononucleosis: evidence for both monocyte and lymphocyte defects.

Authors:  M H Claësson; V Andersen
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R Yarchoan; C A Heilman; S E Pike; V De Seau; R M Blaese
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.